Portage Biotech Inc. (PRTG) Financials

PRTG Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 50.6 million 19.3 million
2023-09-30 92.4 million 25.4 million
2023-06-30 99.1 million 23.7 million
2023-03-31 99.1 million 23.7 million

PRTG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.3 million 736000
2023-09-30 -4.3 million 742
2023-06-30 -4.7 million 662000
2023-03-31 -4.7 million 662000

PRTG Net Income

No data available :(

PRTG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 5.3 million - 275000
2023-09-30 3.4 million - 286000
2023-06-30 10.5 million - 296000
2023-03-31 10.5 million - -

PRTG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 20.9 million
2023-09-30 17.8 million
2023-06-30 17.3 million
2023-03-31 17.6 million

PRTG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.8 million 1.3 million -
2023-09-30 - 4.2 million 1.7 million -
2023-06-30 43 2.2 million 1.8 million -
2023-03-31 - 2.2 million 1.8 million -

PRTG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 15000
2023-09-30 - 14999
2023-06-30 - 11000
2023-03-31 - -

PRTG

Price: $0.31

52 week price:
0.22
4.40

Earnings Per Share: -8.52 USD

P/E Ratio: -0.09

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 55400

Market Capitalization: 9.7 million

Links: